Optical imaging of tumor vascularity associated with proliferation and glucose metabolism in early breast cancer: Clinical application of total hemoglobin measurements in the breast

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Ueda, Shigeto ^a   Nakamiya, Noriko ^a   Matsuura, Kazuo ^a   Shigekawa, Takashi ^a   Sano, Hiroshi ^a   Hirokawa, Eiko ^a   Shimada, Hiroko ^a   Suzuki, Hiroaki ^b   Oda, Motoki ^b   Yamashita, Yutaka ^b   Kishino, Osamu ^a   Kuji, Ichiei ^a   Osaki, Akihiko ^a   Saeki, Toshiaki ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b HAMAMATSU PHOTONICS K K   (Japan)

Author keywords

Breast cancer; Diffuse optical imaging; Glucose metabolism; Total hemoglobin

Indexed keywords

DEOXYHEMOGLOBIN; HEMOGLOBIN; OXYHEMOGLOBIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER STAGING; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; DIFFUSE OPTICAL SPECTROSCOPY; EARLY CANCER; FEMALE; FLUORESCENCE IMAGING; GLUCOSE METABOLISM; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; NEAR INFRARED SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; SPECTROSCOPY; TUMOR VASCULARIZATION; TUMOR VOLUME; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BREAST; BREAST NEOPLASMS; CELL PROLIFERATION; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; HEMOGLOBINS; HUMANS; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; OPTICAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN; YOUNG ADULT;

EID: 84886742092     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-514     Document Type: Article

References (31)

1. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971, 285:1182-1186. 10.1056/NEJM197111182852108, 4938153.
2. Relf M, LeJeune S, Scott PA, Fox S, Smith K, Leek R, Moghaddam A, Whitehouse R, Bicknell R, Harris AL. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res 1997, 57:963-969.
3. Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005, 307:58-62. 10.1126/science.1104819, 15637262.
4. Tromberg BJ, Pogue BW, Paulsen KD, Yodh AG, Boas DA, Cerussi AE. Assessing the future of diffuse optical imaging technologies for breast cancer management. Med Phys 2008, 35:2443-2451. 10.1118/1.2919078, 2809725, 18649477.
5. Ueda Y, Yoshimoto K, Ohmae E, Suzuki T, Yamanaka T, Yamashita D, Ogura H, Teruya C, Nasu H, Ima E, Sakahara H, Oda M, Yamashita Y. Time-resolved optical mammography and its preliminary clinical results. Technol Cancer Res Treat 2011, 10:393-401.
6. Fantini S, Sassaroli A. Near-infrared optical mammography for breast cancer detection with intrinsic contrast. Ann Biomed Eng 2012, 40:398-407. 10.1007/s10439-011-0404-4, 3678374, 21971964.
7. Ohmae E, Oda M, Suzuki T, Yamashita Y, Kakihana Y, Matsunaga A, Kanmura Y, Tamuraet M. Clinical evaluation of time-resolved spectroscopy by measuring cerebral hemodynamics during cardiopulmonary bypass surgery. J Biomed Opt 2007, 12:062112. 10.1117/1.2804931, 18163815.
8. Tromberg BJ, Cerussi A, Shah N, Compton M, Durkin A, Hsiang D, Butler J, Mehta R. Imaging in breast cancer: diffuse optics in breast cancer: detecting tumors in pre-menopausal women and monitoring neoadjuvant chemotherapy. Breast Cancer Res 2005, 7:279-285. 10.1186/bcr1358, 1410753, 16457705.
9. Cerussi A, Shah N, Hsiang D, Durkin A, Butler J, Tromberg BJ. In vivo absorption, scattering, and physiologic properties of 58 malignant breast tumors determined by broadband diffuse optical spectroscopy. J Biomed Opt 2006, 11:044005. 10.1117/1.2337546, 16965162.
10. Zhu Q, Xu C, Guo P, Aguirre A, Yuan B, Huang F, Castilo D, Gamelin J. Optimal probing of optical contrast of breast lesions of different size located at different depths by US localization. Technol Cancer Res Treat 2006, 5:365-380. 2018682, 16866567.
11. Zhu Q, Hegde PU, Ricci A, Kane M, Cronin EB, Ardeshirpour Y, Xu C, Aguirre A, Kurtzman SH, Deckers PJ, Tannenbaum SH. Early-stage invasive breast cancers: potential role of optical tomography with US localization in assisting diagnosis. Radiology 2010, 256:367-378. 10.1148/radiol.10091237, 2909434, 20571122.
12. Collettini F, Martin JC, Diekmann F, Fallenberg E, Engelken F, Ponder S, Kroencke TJ, Hamm B, Poellinger A. Diagnostic performance of a Near-Infrared Breast Imaging system as adjunct to mammography versus X-ray mammography alone. Eur Radiol 2012, 22:350-357. 10.1007/s00330-011-2276-2, 21947512.
13. Patterson MS, Chance B, Wilson BC. Time resolved reflectance and transmittance for the non-invasive measurement of tissue optical properties. Appl Opt 1989, 28:2331-2336. 10.1364/AO.28.002331, 20555520.
14. Ijichi S, Kusaka T, Isobe K, Okubo K, Kawada K, Namba M, Okada H, Nishida T, Imai T, Itoh S. Developmental changes of optical properties in neonates determined by near-infrared time-resolved spectroscopy. Pediatr Res 2005, 58:568-573. 10.1203/01.PDR.0000175638.98041.0E, 16148075.
15. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 2002, 41:154-161.
16. Ueda S, Tsuda H, Sato K, Takeuchi H, Shigekawa T, Matsubara O, Hiraide H, Mochizuki H. Alternative tyrosine phosphorylation of signaling kinases according to hormone receptor status in breast cancer overexpressing the insulin-like growth factor receptor type 1. Cancer Sci 2006, 97:597-604. 10.1111/j.1349-7006.2006.00228.x, 16827799.
17. Umemura S, Kurosumi M, Moriya T, Oyama T, Arihiro K, Yamashita H, Umekita Y, Komoike Y, Shimizu C, Fukushima H, Kajiwara H, Akiyama H. Immunohistochemical evaluation for hormone receptors in breast cancer: a practically useful evaluation system and handling protocol. Breast Cancer 2006, 13:232-235. 10.2325/jbcs.13.232, 16929115.
18. Cuadros M, Villegas R. Systematic review of HER2 breast cancer testing. Appl Immunohistochem Mol Morphol 2009, 17:1-7. 10.1097/PAI.0b013e318169fc1c, 18685491.
19. Kuji I, Imabayashi E, Minagawa A, Matsuda H, Miyauchi T. Brown adipose tissue demonstrating intense FDG uptake in a patient with mediastinal pheochromocytoma. Ann Nucl Med 2008, 22:231-235. 10.1007/s12149-007-0096-x, 18498040.
20. Ueda S, Saeki T, Shigekawa T, Omata J, Moriya T, Yamamoto J, Osaki A, Fujiuchi N, Misumi M, Takeuchi H, Sakurai T, Tsuda H, Tamura K, Ishida J, Abe Y, Imabayashi E, Kuji I, Matsuda H. 18F-fluorodeoxyglucose positron emission tomography optimizes neoadjuvant chemotherapy for primary breast cancer to achieve pathological complete response. Int J Clin Oncol 2012, 17:276-282. 10.1007/s10147-011-0287-2, 21830087.
21. Tanamai W, Chen C, Siavoshi S, Cerussi A, Hsiang D, Butler J, Tromberget B. Diffuse optical spectroscopy measurements of healing in breast tissue after core biopsy: case study. J Biomed Opt 2009, 14:014024. 10.1117/1.3028012, 2872560, 19256712.
22. Groves AM, Shastry M, Rodriguez-Justo M, Malhotra A, Endozo R, Davidson T, Kelleher T, Miles KA, Ell PJ, Keshtgar MR. (1)(8)F-FDG PET and biomarkers for tumour angiogenesis in early breast cancer. Eur J Nucl Med Mol Imaging 2011, 38:46-52. 10.1007/s00259-010-1590-2, 20711577.
23. Goel S, Fukumura D, Jain RK. Normalization of the tumor vasculature through oncogenic inhibition: an emerging paradigm in tumor biology. Proc Natl Acad Sci U S A 2012, 109:E1214. 10.1073/pnas.1203794109, 3356659, 22550180.
24. Shaw RJ. Glucose metabolism and cancer. Curr Opin Cell Biol 2006, 18:598-608. 10.1016/j.ceb.2006.10.005, 17046224.
25. Hsu PP, Sabatini DM. Cancer cell metabolism: Warburg and beyond. Cell 2008, 134:703-707. 10.1016/j.cell.2008.08.021, 18775299.
26. Semenza GL. HIF-1: upstream and downstream of cancer metabolism. Curr Opin Genet Dev 2010, 20:51-56. 10.1016/j.gde.2009.10.009, 2822127, 19942427.
27. Dang CV, Semenza GL. Oncogenic alterations of metabolism. Trends Biochem Sci 1999, 24:68-72. 10.1016/S0968-0004(98)01344-9, 10098401.
28. Larson SM. Positron emission tomography-based molecular imaging in human cancer: exploring the link between hypoxia and accelerated glucose metabolism. Clin Cancer Res 2004, 10:2203-2204. 10.1158/1078-0432.CCR-0002-4, 15073092.
29. Sorlie T, Perou CM, Tibshirani R, Turid A, Geislerg S, Johnsenb H, Hastiee T, Eisenh MB, Rijni MVD, Jeffreyj SS, Thorsenk T, Quistl H, Matesec JC, Brownm PO, Botsteinc D, Lønningg PE, Børresen-Daleet AL. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001, 98:10869-10874. 10.1073/pnas.191367098, 58566, 11553815.
30. Brown JQ, Wilke LG, Geradts J, Kennedy SA, Palmer GM, Ramanujam N. Quantitative optical spectroscopy: a robust tool for direct measurement of breast cancer vascular oxygenation and total hemoglobin content in vivo. Cancer Res 2009, 69:2919-2926. 10.1158/0008-5472.CAN-08-3370, 2677720, 19293184.
31. Yang WT. Emerging techniques and molecular imaging in breast cancer. Semin Ultrasound CT MR 2011, 32:288-299. 10.1053/j.sult.2011.03.003, 21782119.